Connect Biopharma Holdings Limited
PublicConnect Biopharma Holdings Limited is now publicly traded
The data on this page reflects Connect Biopharma Holdings Limited's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Mar 23, 2021
Last Round
Series C
Aug 24, 2020
Total Funding Raised
$394.9M
Company Overview
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company that develops therapies for inflammatory diseases such as asthma and chronic obstructive pulmonary disease (COPD).
Sector
Healthcare
AI Layer
Non-AI
Keywords
Connect Biopharma Holdings Limited Comparables
Compare Connect Biopharma Holdings Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mabgeek Biotechnology | 79% | |
| Belenos Biosciences Inc. | 76% | |
| Kinaset Therapeutics | 63% |
Connect Biopharma Holdings Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Mar 23, 2021 | ||||
| Series C | Aug 24, 2020 | ||||
| Series B | Dec 20, 2018 | ||||
| Pre Seed | Jan 1, 2017 |
Key People
Founding team and executive leadership
Connect Biopharma Holdings Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Jefferies | IPO |
| RA Capital Management | Series C |
| Boxer Capital | Series C |
| Co-Win Ventures | Series B |
| China International Capital Corporation | IPO |
| Lapam Capital | Pre Seed |
| Northern Light Venture Capital | Series B, Pre Seed |
Connect Biopharma Holdings Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access